76 related articles for article (PubMed ID: 25124640)
1. Baseline stimulated thyroglobulin level as a good predictor of successful ablation after adjuvant radioiodine treatment for differentiated thyroid cancers.
Fatima N; uz Zaman M; Ikram M; Akhtar J; Islam N; Masood Q; Zaman U; Zaman A
Asian Pac J Cancer Prev; 2014; 15(15):6443-7. PubMed ID: 25124640
[TBL] [Abstract][Full Text] [Related]
2. Outcome after ablation in patients with low-risk thyroid cancer (ESTIMABL1): 5-year follow-up results of a randomised, phase 3, equivalence trial.
Schlumberger M; Leboulleux S; Catargi B; Deandreis D; Zerdoud S; Bardet S; Rusu D; Godbert Y; Buffet C; Schvartz C; Vera P; Morel O; Benisvy D; Bournaud C; Toubert ME; Kelly A; Benhamou E; Borget I
Lancet Diabetes Endocrinol; 2018 Aug; 6(8):618-626. PubMed ID: 29807824
[TBL] [Abstract][Full Text] [Related]
3. Early Post-operative Stimulated Serum Thyroglobulin: Role in Preventing Unnecessary Radioactive Iodine Treatment in Low to Intermediate Risk Papillary Thyroid Cancer.
Sezer H; Yazıcı D; Terzioğlu T; Tezelman S; Canbaz HB; Yerlikaya A; Demirkol MO; Kapran Y; Çolakoğlu B; Çilingiroğlu EN; Alagöl F
Am Surg; 2023 Dec; 89(12):5996-6004. PubMed ID: 37309609
[TBL] [Abstract][Full Text] [Related]
4. Stimulated thyroglobulin and pre-ablation antithyroglobulin antibody products can predict the response to radioiodine therapy of TgAb-positive differentiated thyroid cancer patients: a retrospective study.
Han N; Lu C; Li J; Wang C; Zhao Z; Zhang Y; Liu X; Si Z; Wang G; Wang Z; Li F; Wang X
Front Endocrinol (Lausanne); 2023; 14():1222470. PubMed ID: 37810895
[TBL] [Abstract][Full Text] [Related]
5. Higher adjuvant radioactive iodine therapy dosage helps intermediate-risk papillary thyroid carcinoma patients achieve better therapeutic effect.
Li X; Zheng H; Ma C; Ji Y; Wang X; Sun D; Meng Z; Zheng W
Front Endocrinol (Lausanne); 2023; 14():1307325. PubMed ID: 38298190
[TBL] [Abstract][Full Text] [Related]
6. Stimulated thyroglobulin and diagnostic 131-iodine whole-body scan as a predictor of distant metastasis and association with response to treatment in pediatric thyroid cancer patients.
Garcia Alves-Junior PA; de Andrade Barreto MC; de Andrade FA; Bulzico DA; Corbo R; Vaisman F
Endocrine; 2024 Feb; ():. PubMed ID: 38296913
[TBL] [Abstract][Full Text] [Related]
7. Sufficiency of a Single Negative Thyroglobulin Standard for Judging the Success of Ablation in Low- and Intermediate-risk Differentiated Thyroid Cancer: A Retrospective Study.
Long Y; Jin J; Zhang W
Endocr Metab Immune Disord Drug Targets; 2024 Jan; ():. PubMed ID: 38192150
[TBL] [Abstract][Full Text] [Related]
8. TSH ≥30 mU/L may not be necessary for successful 131I remnant ablation in patients with differentiated thyroid cancer.
Ju N; Hou L; Song H; Qiu Z; Wang Y; Sun Z; Luo Q; Shen C
Eur Thyroid J; 2023 Aug; 12(4):. PubMed ID: 37022724
[TBL] [Abstract][Full Text] [Related]
9. Basal or stimulated thyroglobulin in evaluating response to treatment in papillary thyroid carcinoma? A retrospective cohort study.
Barreto L; Ferreira DCG; Corrente JE; Soares CSP; Oliveira CC; Terra SA; Moriguchi SM; Koga KH; Tagliarini JV; da Silva Mazeto GMF
Hormones (Athens); 2024 Mar; 23(1):97-106. PubMed ID: 38015413
[TBL] [Abstract][Full Text] [Related]
10. The Prognostic Power of Preablation Stimulated Thyroglobulin in Children With Differentiated Thyroid Cancer.
Nesari Javan F; Askari E; Shafiei S; Roshanravan V; Aghaei A; Ayati N; Zakavi SR
Endocr Pract; 2024 Mar; 30(3):209-217. PubMed ID: 38092290
[TBL] [Abstract][Full Text] [Related]
11. Radioiodine remnant ablation in low-risk differentiated thyroid cancer patients who had R0 dissection is an over treatment.
Bal C; Ballal S; Soundararajan R; Chopra S; Garg A
Cancer Med; 2015 Jul; 4(7):1031-8. PubMed ID: 25755077
[TBL] [Abstract][Full Text] [Related]
12. Thyroid cancer presentation and treatment in the United States.
Enewold L; Harlan LC; Stevens JL; Sharon E
Ann Surg Oncol; 2015; 22(6):1789-97. PubMed ID: 25361888
[TBL] [Abstract][Full Text] [Related]
13. Do radioiodine-avid lymph nodes from differentiated thyroid cancer on the initial posttherapy scan need repeated
Jiang Y; Liu S; Qiu X; Huo Y; Zhang X; Cai H; Lv Z; Ma C
Front Endocrinol (Lausanne); 2023; 14():1099449. PubMed ID: 37324259
[TBL] [Abstract][Full Text] [Related]
14. Ablation Rates and Long-Term Outcome Following Low-Dose Radioiodine for Differentiated Thyroid Cancer in the West of Scotland: A Retrospective Analysis.
Graham K; Tough F; Belikova H; Wotherspoon I; Colville D; Reed N
Endocr Pract; 2024 Apr; 30(4):327-332. PubMed ID: 38184240
[TBL] [Abstract][Full Text] [Related]
15. Radioactive iodine therapy for follicular thyroid cancer: a 15 years follow-up study of Chinese patients.
Shi H; Yang B; Feng JI; Li JH; Cheng X; Li YJ; Fu Y; Xu XD; Qian LH; Tang LJ; Liu W
Nucl Med Commun; 2024 Mar; 45(3):169-174. PubMed ID: 38095140
[TBL] [Abstract][Full Text] [Related]
16. Combined clinical variable and radiomics of post-treatment total body scan for prediction of successful I-131 ablation in low-risk papillary thyroid carcinoma patients.
Chantadisai M; Wongwijitsook J; Ritlumlert N; Rakvongthai Y
Sci Rep; 2024 Feb; 14(1):5001. PubMed ID: 38424177
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the clinical factors affecting excellent response of Iodine-131 treatment for pulmonary metastases from differentiated thyroid cancer.
Wu XY; Li B; Zhang J; Duan LL; Hu BX; Gao YJ
Heliyon; 2023 Nov; 9(11):e20853. PubMed ID: 37928010
[TBL] [Abstract][Full Text] [Related]
18. Predictive risk factors for distant metastasis in pediatric differentiated thyroid cancer from Saudi Arabia.
Parvathareddy SK; Siraj AK; Annaiyappanaidu P; Siraj N; Al-Rasheed M; Al-Haqawi W; Qadri Z; Siddiqui K; Al-Sobhi SS; Al-Dayel F; Al-Kuraya KS
Front Endocrinol (Lausanne); 2023; 14():1228049. PubMed ID: 37867506
[TBL] [Abstract][Full Text] [Related]
19. Current Advances in Thyroid Cancer Management. Are We Ready for the Epidemic Rise of Diagnoses?
Rusinek D; Chmielik E; Krajewska J; Jarzab M; Oczko-Wojciechowska M; Czarniecka A; Jarzab B
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28829399
[TBL] [Abstract][Full Text] [Related]
20. Stimulating thyroglobulin to TSH ratio predict long-term efficacy of
Yin X; Lu C; Sun D; Ji Y; Wang Y; Zheng H; Ma Z; Jia Q; Tan J; Zheng W
Endocrine; 2024 Jan; ():. PubMed ID: 38172344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
